Rebalix
Logo JPMorganJPMorgan · sheet of 5 September 2026
ETF sheet · official issuer and register data

Europe Research Enhanced Index Equity Active UCITS ETF

JREE · IE00BF4G7183 · class JPM - EUR (acc) · EUR · domicile Ireland
Equity · EuropeactiveSFDR art. 8
Comparison benchmark: M7EU
TER
0.24%+ trans. 0.16%
Fund size
3 bn EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Gestione attiva (dal KID)active management
Income
Accumulating
Launch 10 Oct 2018 · costs from the KID as of 2 Sept 2026 · 153 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
Investment Objective: The Sub-Fund aims to achieve a long-term return in excess of MSCI Europe Index (Total Return Net) (the "Benchmark") by actively investing primarily in a portfolio of European companies. Investment Policy: The investment strategy. Sub-Fund pursues an actively-managed The Sub-Fund aims to invest at least 67% of its assets (excluding assets held for ancillary liquidity purposes) in equity securities of companies that are domiciled in, or carry out the main part of their economic activity in, a European country. At least 51% of the…

Performance since series start (in euro) — base 100

10 Oct 20183 Sept 2026 · dividends reinvested where declared by the issuer
201920212023202523382229
High 233 (12 Aug 2026) · low 82 (18 Mar 2020) · last 229. Past performance is not indicative of future results.

Returns in euro

1 year+24.0%
3 years+51.0%
5 years+59.9%
10 yearsseries too young
Since series start+128.7%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.21%12.28%13.80%
Max drawdown−9.81%−16.12%−18.99%
Sharpe1.550.900.56
Sortino2.421.260.79
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · JREE · IE00BF4G71831
RebalixJREE · IE00BF4G7183 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 153 securities · top-10 weight = 24.0%
Top holdingsWeight
ASML HOLDING NV /EUR/5.0%
HSBC HOLDINGS PLC /GBP/2.4%
SIEMENS AG-REG /EUR/2.4%
ALLIANZ SE REGISTERED /EUR/2.3%
ASTRAZENECA PLC /GBP/2.1%
SHELL PLC-NEW /GBP/2.0%
NESTLE SA-REG /CHF/2.0%
NOVARTIS AG-REG /CHF/2.0%
ROCHE HOLDING AG /CHF/2.0%
BANCO SANTANDER SA /EUR/1.9%
Countries (% of fund)
United Kingdom23.7%France16.3%Germany15.6%Switzerland12.3%Netherlands11.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
JREE · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · wl.fundsquare.net/serv/down-doc/request?cdClient=jpmorgan&isin=IE00BF4
Factsheet · jp.techrules.com/rebrandingPDF/LoadPdf.aspx?ShareClassId=13078&country
Prospectus · wl.fundsquare.net/serv/down-doc/request?cdClient=jpmorgan&isin=IE00BF4
The live sheet, always up to date
rebalix.com/en/etf/IE00BF4G7183
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · JREE · IE00BF4G71832